LEADER 02246nmm a2200325 u 4500
001 EB001082141
003 EBX01000000000000000841548
005 00000000000000.0
007 cr|||||||||||||||||||||
008 151019 ||| eng
100 1 |a Bel, Elisabeth 
245 0 0 |a Management of difficult asthma  |h Elektronische Ressource  |c Elisabeth Bel 
260 |a London  |b Henry Stewart Talks  |c 2011, 2011 
300 |a 1 online resource (1 streaming video file (20 min.)  |b color, sound) 
505 0 |a Difficult asthma and severe refractory asthma -- Heterogeneous reasons for severe asthma -- "High dose" therapy -- Treatments for severe asthma -- Eosinophilic vs. non eosinophilic inflammation -- Effect of CRS treatment on asthma -- Mechanism of action of anti IgE -- Effect of anti IgE on severe asthma exacerbations -- Effect of anti IL-5 (mepolizumab) on spontaneous asthma exacerbations -- Clarithromycin in neutrophilic asthma -- Macrolides in chronic stable asthma -- Mechanisms of asthma severity in obese patients -- Implications for the future 
653 |a Asthma / complications 
653 |a Asthma / drug therapy 
653 |a Asthma / therapy 
653 |a Antiasthmatic agents 
653 |a Eosinophils / metabolism 
653 |a Asthma / Treatment 
653 |a Anti-Asthmatic Agents / therapeutic use 
653 |a Asthma / Chemotherapy 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a Advances in asthma : new mechanisms, management strategies and treatments 
500 |a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web. - System requirements: Browser compatibility: updated Mozilla Firefox, Google Chrome, Safari or Internet Explorer 8+. Browser settings: enable JavaScript, enable cookies from the Henry Stewart Talks site. Required Desktop Browser plugins & viewers: Updated Adobe Flash Player & Adobe Acrobat Reader. Mobile device & operating system versions: Android v4.0+, iPhone 4+ (iOS v6.x+), iPad 2+ (iOS v6.x+), BlackBerry OS v7.0+, Windows Phone v6.5.1+ 
856 4 0 |u https://hstalks.com/bs/2177  |x Verlag  |z Streaming video file 
856 4 2 |u https://hstalks.com/bs/p/640  |3 Series 
082 0 |a 570